SCHEMBL74736

SCHEMBL74736

[CH2]CCNC(=O)CCCCCCCCCCCCCCCCCCCCC

nearest known ligand 0.67

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FAAH O00519 6/20 0.67
DNM1 Q05193 2/20 0.62
CASP2 P42575 1/20 0.62
NAAA Q02083 1/20 0.58
HSP90AA1 P07900 1/20 0.55
EPHX2 P34913 3/20 0.54
SELP P16109 1/20 0.54
CNR1 P21554 2/20 0.53
ALDH1A1 P00352 1/20 0.53
HPGD P15428 1/20 0.53
TRPV1 Q8NER1 1/20 0.53
CNR2 P34972 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8756338 1.00 FAAH (0.67) FAAHDNM1CASP2NAAAHSP90AA1
SCHEMBL15754645 1.00 FAAH (0.67) FAAHDNM1CASP2NAAAHSP90AA1
SCHEMBL15754583 1.00 FAAH (0.67) FAAHDNM1CASP2NAAAHSP90AA1
SCHEMBL117794 1.00 FAAH (0.67) FAAHDNM1CASP2NAAAHSP90AA1
SCHEMBL430817 1.00 FAAH (0.67) FAAHDNM1CASP2NAAAHSP90AA1
SCHEMBL15754680 1.00 FAAH (0.67) FAAHDNM1CASP2NAAAHSP90AA1
SCHEMBL9469998 1.00 FAAH (0.67) FAAHDNM1CASP2NAAAHSP90AA1
SCHEMBL5244402 1.00 FAAH (0.67) FAAHDNM1CASP2NAAAHSP90AA1
SCHEMBL713149 1.00 FAAH (0.67) FAAHDNM1CASP2NAAAHSP90AA1
SCHEMBL9470356 1.00 FAAH (0.67) FAAHDNM1CASP2NAAAHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230338324-A1 METHOD FOR TREATING RHEUMATOID ARTHRITIS THE WILLIAM M YARBROUGH FOUNDATION 2023-10-26 US claimed
US-20230263763-A1 METHOD FOR TREATING INFECTIOUS DISEASES WITH ISOTHIOCYANATE FUNCTIONAL COMPOUNDS THE WILLIAM M YARBROUGH FOUNDATION 2023-08-24 US claimed
US-20230255920-A1 METHOD FOR TREATING METASTATIC PROSTATE CANCER THE WILLIAM M YARBROUGH FOUNDATION 2023-08-17 US claimed
US-11045404-B2 Thickening cleansing compositions and applications and methods of preparation thereof Sino Lion USA (US) 2021-06-29 US claimed
US-20200354652-A1 PARTICLES FOR THROUGH THE WASH LAUNDRY SOFTENING THE PROCTER & GAMBLE COMPANY 2020-11-12 US claimed
WO-2020227737-A1 PARTICLES FOR THROUGH THE WASH LAUNDRY SOFTENING THE PROCTER & GAMBLE COMPANY (US) 2020-11-12 WO claimed
EP-3736320-A1 PARTICLES FOR THROUGH THE WASH LAUNDRY SOFTENING The Procter & Gamble Company (US) 2020-11-11 EP claimed
US-20190282480-A1 THICKENING CLEANSING COMPOSITIONS AND APPLICATIONS AND METHODS OF PREPARATION THEREOF Sino Lion USA LLC (US) 2019-09-19 US claimed
EP-3390598-A1 THICKENING CLEANSING COMPOSITIONS AND APPLICATIONS AND METHODS OF PREPARATION THEREOF Sino Lion USA LLC (US) 2018-10-24 EP claimed
EP-3362037-A1 LIQUID HAIR DYE WITH OPTIMIZED DYING PERFORMANCE AND CARE Henkel AG & Co. KGaA (DE) 2018-08-22 EP claimed
US-6376455-B1 FABRIC SOFTENER, QUATERNARY FATTY ACID AMINO ALCOHOL ESTERS OF METHYLETHANOLISOPROPANOLAMINE (MEIPA) WITH FATTY ACIDS IN THE RATIO OF FROM 1:1.5 TO 1:2 WITH USE OF MONOFUNCTIONAL ALCOHOLS OR BIFUNCTIONAL ALCOHOLS. GOLDSCHMIDT REWO GMBH & CO. KG (DE) 2002-04-23 US claimed
US-6329353-B1 Clear personal care formulations containing quaternary ammonium compounds and other nitrogen-containing compounds GOLDSCHMIDT CHEMICAL CORPORATION 2001-12-11 US claimed
US-6211139-B1 Polyester polyquaternary compounds, compositions containing them, and use thereof GOLDSCHMIDT CHEMICAL CORPORATION 2001-04-03 US claimed
EP-1076554-A1 CLEAR PERSONAL CARE FORMULATIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS AND OTHER NITROGEN-CONTAINING COMPOUNDS Goldschmidt Chemical Company (US) 2001-02-21 EP claimed
EP-1045891-A1 NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF Goldschmidt Chemical Corporation (US) 2000-10-25 EP claimed
WO-1999058106-A1 CLEAR PERSONAL CARE FORMULATIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS AND OTHER NITROGEN-CONTAINING COMPOUNDS GOLDSCHMIDT CHEMICAL COMPANY (US) 1999-11-18 WO claimed
US-5948416-A LEAVE ON SKIN CARE COMPOSITION; HYDROPHOBIC STRUCTURING AGENT; HYDROPHILIC CATIONIC SURFACTANT; ACTIVE COMPOUND THE PROCTER & GAMBLE COMPANY (US) 1999-09-07 US claimed
WO-1999035223-A1 NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF WITCO CORPORATION (US) 1999-07-15 WO claimed
WO-1999035120-A1 NOVEL QUATERNARY AMMONIUM COMPOUNDS, COMPOSITIONS CONTAINING THEM, AND USES THEREOF WITCO CORPORATION (US) 1999-07-15 WO claimed
WO-1999019433-A1 SHOWER AND SHAVE BODY WASH AVON PRODUCTS, INC. (US) 1999-04-22 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200354652-A1 PARTICLES FOR THROUGH THE WASH LAUNDRY SOFTENING CUTA, PWWP2B, HACD2 FAAH 14/4885DNM1 4723/4885CASP2 2406/4885
US-20190282480-A1 THICKENING CLEANSING COMPOSITIONS AND APPLICATIONS AND METHODS OF PREPARATION THEREOF CUTA, DSG1, PHOSPHO1 FAAH 86/4885DNM1 1030/4885CASP2 4185/4885
US-20230338324-A1 METHOD FOR TREATING RHEUMATOID ARTHRITIS MIF, TNF, MMP12 FAAH 1272/4885DNM1 3487/4885CASP2 808/4885
US-20230263763-A1 METHOD FOR TREATING INFECTIOUS DISEASES WITH ISOTHIOCYANATE FUNCTIONAL COMPOUNDS CFTR, TST, ICMT FAAH 2592/4885DNM1 3945/4885CASP2 420/4885
US-11045404-B2 Thickening cleansing compositions and applications and methods of preparation thereof CUTA, DSG1, PHOSPHO1 FAAH 86/4885DNM1 1030/4885CASP2 4185/4885
US-20230255920-A1 METHOD FOR TREATING METASTATIC PROSTATE CANCER BPHL, KLK3, ACP3 FAAH 1303/4885DNM1 3577/4885CASP2 2141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.